Abstract:Ultrasound (US)-driven sonodynamic therapy (SDT) has demonstrated wide application prospects in the eradication of deep-seated bacterial infections due to its noninvasiveness, site-confined irradiation, and high-tissue-penetrating capability. However, the ineffective accumulation of sonosensitizers at the infection site, the hypoxic microenvironment, as well as rapid depletion of oxygen during SDT greatly hamper the therapeutic efficacy of SDT. Herein, an US-switchable nanozyme system was proposed for the controllable generation of catalytic oxygen and sonosensitizer-mediated reactive oxygen species during ultrasound activation, thereby alleviating the hypoxia-associated barrier and augmenting SDT efficacy. This nanoplatform () was easily prepared by bridging enzyme-catalytic nanoplates with the organic sonosensitizer meso-tetra(4-carboxyphenyl)porphine (T790). It was really interesting to find that the modification of T790 onto could significantly block the catalase-like activity of , whereas upon US irradiation, the nanozyme activity was effectively recovered to catalyze the decomposition of endogenous H2O2 into O2. Such "blocking and activating" enzyme activity was particularly important for decreasing the potential toxicity and side effects of nanozymes on normal tissues and has potential to realize active, controllable, and disease-loci-specific nanozyme catalytic behavior. Taking advantage of this US-switchable enzyme activity, outstanding accumulation in infection sites, as well as excellent biocompatibility, the SDT nanosystem was successfully applied to eradicate methicillin-resistant Staphylococcus aureus (MRSA)-induced myositis, and the sonodynamic therapeutic progression was noninvasively monitored by photoacoustic imaging and magnetic resonance imaging. The developed US-switchable nanoenzyme system provides a promising strategy for augmenting sonodynamic eradication of deep-seated bacterial infection actively, controllably, and precisely.

Sonodynamic Antimicrobial Chemotherapy: an Emerging Alternative Strategy for Microbial Inactivation

Recent Developments of Sonodynamic Therapy in Antibacterial Application

Emerging nanosonosensitizers augment sonodynamic-mediated antimicrobial therapies

Sonodynamic inactivation of gram-negative and gram-positive bacteria in the presence of phenothiazine compounds toluidine blue and azurin A

The promise of low-intensity ultrasound: A review on sonosensitizers and sonocatalysts by ultrasonic activation for bacterial killing

Sonodynamic therapy-based nanoplatforms for combating bacterial infections

Sonoactivated Chemodynamic Therapy: A Robust ROS Generation Nanotheranostic Eradicates Multidrug‐Resistant Bacterial Infection

Sonodynamic inactivation of Gram-positive and Gram-negative bacteria using a Rose Bengal-antimicrobial peptide conjugate

Application of antimicrobial sonodynamic therapy as a potential treatment modality in dentistry: A literature review

A Comprehensive Review of Inorganic Sonosensitizers for Sonodynamic Therapy

Nanosonosensitizer Optimization for Enhanced Sonodynamic Disease Treatment

Investigation into the Sonodynamic Activity of Three Newly Synthesized Derivatives of Ciprofloxacin

New strategies to enhance antimicrobial photo-sonodynamic therapy based on nanosensitizers against bacterial infections

Stimuli responsive nanosonosensitizers for sonodynamic therapy

Ultrasound-Switchable Nanozyme Augments Sonodynamic Therapy against Multidrug-Resistant Bacterial Infection

Beyond Antibiotics: Photo/Sonodynamic Approaches for Bacterial Theranostics

Recent Advances of Sonodynamic Therapy in Cancer Treatment

Carbon dots-based nanoclusters for sonodynamic therapy of bacterial infection enhanced by deep biofilm penetration and hypoxia alleviation

Inorganic Sonosensitizers for Sonodynamic Therapy in Cancer Treatment

Natural products in the discovery of novel sonosensitizers